Literature DB >> 27532026

Integration of multimodal RNA-seq data for prediction of kidney cancer survival.

Matt Schwartzi1, Martin Parkl1, John H Phanl1, May D Wang1.   

Abstract

Kidney cancer is of prominent concern in modern medicine. Predicting patient survival is critical to patient awareness and developing a proper treatment regimens. Previous prediction models built upon molecular feature analysis are limited to just gene expression data. In this study we investigate the difference in predicting five year survival between unimodal and multimodal analysis of RNA-seq data from gene, exon, junction, and isoform modalities. Our preliminary findings report higher predictive accuracy-as measured by area under the ROC curve (AUC)-for multimodal learning when compared to unimodal learning with both support vector machine (SVM) and k-nearest neighbor (KNN) methods. The results of this study justify further research on the use of multimodal RNA-seq data to predict survival for other cancer types using a larger sample size and additional machine learning methods.

Entities:  

Year:  2015        PMID: 27532026      PMCID: PMC4983433          DOI: 10.1109/BIBM.2015.7359913

Source DB:  PubMed          Journal:  Proceedings (IEEE Int Conf Bioinformatics Biomed)        ISSN: 2156-1125


  9 in total

1.  Minimum redundancy feature selection from microarray gene expression data.

Authors:  Chris Ding; Hanchuan Peng
Journal:  J Bioinform Comput Biol       Date:  2005-04       Impact factor: 1.122

2.  A postoperative prognostic nomogram for renal cell carcinoma.

Authors:  M W Kattan; V Reuter; R J Motzer; J Katz; P Russo
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

Review 3.  Tumor biology and prognostic factors in renal cell carcinoma.

Authors:  David S Finley; Allan J Pantuck; Arie S Belldegrun
Journal:  Oncologist       Date:  2011

4.  Epidemiology of cancers of the kidney in an Australian population.

Authors:  Colin Luke; Nicole Sargent; Ken Pittman; Tim Price; David Roder
Journal:  Asian Pac J Cancer Prev       Date:  2011

5.  Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma.

Authors:  Tarek M Mekhail; Rony M Abou-Jawde; Gabriel Boumerhi; Sareena Malhi; Laura Wood; Paul Elson; Ronald Bukowski
Journal:  J Clin Oncol       Date:  2005-02-01       Impact factor: 44.544

6.  Classification models for clear cell renal carcinoma stage progression, based on tumor RNAseq expression trained supervised machine learning algorithms.

Authors:  Zeenia Jagga; Dinesh Gupta
Journal:  BMC Proc       Date:  2014-10-13

7.  Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma.

Authors:  Alexander S Parker; Bradley C Leibovich; Christine M Lohse; Yuri Sheinin; Susan M Kuntz; Jeanette E Eckel-Passow; Michael L Blute; Eugene D Kwon
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

8.  Composite three-marker assay for early detection of kidney cancer.

Authors:  Dong Su Kim; Young Deuk Choi; Mihyang Moon; Suki Kang; Jong-Baeck Lim; Kyung Min Kim; Kyung Mok Park; Nam Hoon Cho
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03       Impact factor: 4.254

9.  Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma.

Authors:  Robert J Motzer; Ronald M Bukowski; Robert A Figlin; Thomas E Hutson; M Dror Michaelson; Sindy T Kim; Charles M Baum; Michael W Kattan
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

  9 in total
  2 in total

Review 1.  The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors.

Authors:  Matteo Giulietti; Monia Cecati; Berina Sabanovic; Andrea Scirè; Alessia Cimadamore; Matteo Santoni; Rodolfo Montironi; Francesco Piva
Journal:  Diagnostics (Basel)       Date:  2021-01-30

Review 2.  SurviveAI: Long Term Survival Prediction of Cancer Patients Based on Somatic RNA-Seq Expression.

Authors:  Omri Nayshool; Nitzan Kol; Elisheva Javaski; Ninette Amariglio; Gideon Rechavi
Journal:  Cancer Inform       Date:  2022-10-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.